John Owen Brennan is Director of ImmunityBio, Inc.. Currently has a direct ownership of 25,000 shares of IBRX, which is worth approximately $158,000. The most recent transaction as insider was on Jun 02, 2023, when has been sold 25,000 shares (Common Stock) at a price of $2.81 per share, resulting in proceeds of $70,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25K
0% 3M change
0% 12M change
Total Value Held $158,000

John Owen Brennan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2023
BUY
Open market or private purchase
$70,250 $2.81 p/Share
25,000 Added 50.0%
25,000 Common Stock
JOB

John Owen Brennan

Director
San Diego, CA

Track Institutional and Insider Activities on IBRX

Follow ImmunityBio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBRX shares.

Notify only if

Insider Trading

Get notified when an Immunity Bio, Inc. insider buys or sells IBRX shares.

Notify only if

News

Receive news related to ImmunityBio, Inc.

Track Activities on IBRX